Hepion Pharmaceuticals is a clinical stage biopharmaceutical company.
Hepion Pharmaceuticals has raised $700K in total funding. The most recent round was Post-IPO Equity. The last funding was announced in April 2026.
Hepion Pharmaceuticals is headquartered in Edison, United States.
Hepion Pharmaceuticals is a clinical stage biopharmaceutical company.
Hepion Pharmaceuticals is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Hepion Pharmaceuticals — Funding & Investors." VCBacked, April 21, 2026, https://www.vcbacked.co/company/hepion-pharmaceuticals. Accessed August 14, 2026.
VCBacked. (2026). Hepion Pharmaceuticals — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/hepion-pharmaceuticals
{{cite web |title=Hepion Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/hepion-pharmaceuticals |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated